Skeletal muscle hemojuvelin is dispensable for systemic iron homeostasis.

Hepcidin, a hormone produced mainly by the liver, has been shown to inhibit both intestinal iron absorption and iron release from macrophages. Hemojuvelin, a glycophosphatidyl inositol-linked membrane protein, acts as a bone morphogenetic protein coreceptor to activate hepcidin expression through a SMAD signaling pathway in hepatocytes. In the present study, we show in mice that loss of hemojuvelin specifically in the liver leads to decreased liver hepcidin production and increased tissue and serum iron levels. Although it does not have any known function outside of the liver, hemojuvelin is expressed at very high levels in cardiac and skeletal muscle. To explore possible roles for hemojuvelin in skeletal muscle, we analyzed conditional knockout mice that lack muscle hemojuvelin. The mutant animals had no apparent phenotypic abnormalities. We found that systemic iron homeostasis and liver hepcidin expression were not affected by loss of hemojuvelin in skeletal muscle regardless of dietary iron content. We conclude that, in spite of its expression pattern, hemojuvelin is primarily important in the liver.

[1]  C. Enns,et al.  Matriptase-2- and Proprotein Convertase-cleaved Forms of Hemojuvelin Have Different Roles in the Down-regulation of Hepcidin Expression* , 2010, The Journal of Biological Chemistry.

[2]  A. Bosserhoff,et al.  Evidence for a Lack of a Direct Transcriptional Suppression of the Iron Regulatory Peptide Hepcidin by Hypoxia-Inducible Factors , 2009, PloS one.

[3]  C. Peyssonnaux,et al.  HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. , 2009, The Journal of clinical investigation.

[4]  M. Roth,et al.  Lack of the bone morphogenetic protein BMP6 induces massive iron overload , 2009, Nature Genetics.

[5]  Yin Xia,et al.  BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism , 2009, Nature Genetics.

[6]  Jerry Kaplan,et al.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.

[7]  N. Andrews,et al.  Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.

[8]  Clara Camaschella,et al.  Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. , 2008, Blood.

[9]  T. Ganz,et al.  Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. , 2008, Blood cells, molecules & diseases.

[10]  Yin Xia,et al.  Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. , 2007, The Journal of clinical investigation.

[11]  V. Nizet,et al.  Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). , 2007, The Journal of clinical investigation.

[12]  L. Silvestri,et al.  Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. , 2007, Blood.

[13]  M. Hentze,et al.  STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. , 2007, Blood.

[14]  N. Andrews,et al.  Interleukin-6 induces hepcidin expression through STAT3. , 2006, Blood.

[15]  Raymond T Chung,et al.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.

[16]  Xiaoling Xu,et al.  A Role of Smad4 in Iron Metabolism through the Positive Regulation of Hepcidin Expression , 2022 .

[17]  S. Arber,et al.  Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. , 2005, The Journal of clinical investigation.

[18]  G. Pinkus,et al.  A mouse model of juvenile hemochromatosis. , 2005, The Journal of clinical investigation.

[19]  T. Ganz,et al.  Hepcidin is decreased in TFR2 hemochromatosis. , 2005, Blood.

[20]  T. Ganz,et al.  Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. , 2005, Blood.

[21]  Marie-Pierre Dubé,et al.  Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis , 2004, Nature Genetics.

[22]  D. Purdie,et al.  Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis , 2003, The Lancet.

[23]  D. Girelli,et al.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.

[24]  M. Loda,et al.  Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. , 2002, Blood.

[25]  Gaël Nicolas,et al.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. , 2002, The Journal of clinical investigation.

[26]  C. Beaumont,et al.  Severe iron deficiency anemia in transgenic mice expressing liver hepcidin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Beaumont,et al.  Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.

[29]  Dena E. Cohen,et al.  The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. , 1999, Blood.